Childhood asthma & cystic fibrosis

This guide covers two separate childhood lung conditions that parents often want to understand together because both affect breathing. They are not the same illness, and a child has one or the other, not a mix of the two.

Childhood asthma is a long-term (chronic) condition in which the small airways inside the lungs become inflamed and over-sensitive. When something irritates them, the airway walls swell, the muscles around them tighten, and extra mucus is produced. This narrows the airways and makes it harder for air to flow, which is why a child may wheeze (a whistling sound when breathing), cough, feel breathless, or describe a tight chest. Asthma is the most common long-term illness of childhood, and it often begins before the age of five.

Cystic fibrosis (CF) is a rarer, inherited (passed down in the genes) condition. A faulty gene causes the body to make mucus that is unusually thick and sticky. Instead of staying thin and protective, this mucus clogs the airways and the tubes of the pancreas (a gland that helps with digestion). Over time this can lead to repeated chest infections and difficulty absorbing food. CF affects the whole body, not just the lungs.

The most important difference: asthma is generally about inflamed, twitchy airways, while CF is about thick mucus caused by a single faulty gene. Both can be looked after well by a specialist team, and children with either condition can lead full, active lives.

Asthma is often described by what sets it off and how often symptoms appear, rather than by rigid medical categories. You may hear these everyday terms:

• Allergic asthma — symptoms triggered by things the child is allergic to, such as pollen, house dust mites, mould, or animal fur.
• Non-allergic asthma — triggered by colds and other infections, cold air, smoke, or air pollution.
• Exercise-induced symptoms — coughing or wheezing brought on by physical activity, especially in cold, dry air.

Many children have a mix of these. Doctors also grade asthma as mild, moderate, or severe depending on how often symptoms occur and how much medicine is needed to keep them under control.

Cystic fibrosis is often grouped as:

• Classic CF — affects several organs (lungs, pancreas, sinuses, and others) and is usually picked up in early childhood.
• Atypical or non-classic CF — a milder pattern that may affect mainly one part of the body or cause on-and-off symptoms, sometimes diagnosed later in childhood or even in adulthood.

CF is also classed by the exact change (mutation) in the responsible gene, called CFTR. The mutation a child carries matters because it can affect which modern medicines may help. The most common mutation worldwide is called F508del.

Asthma. The exact cause is not fully understood, but it appears to come from a mix of genes and environment. A child is more likely to develop asthma if there is a family history of asthma, eczema, or hay fever. Other factors that raise the chance include exposure to tobacco smoke (including before birth), being born early, frequent chest infections in early life, and air pollution. Things that bring on symptoms once asthma exists are called triggers and include colds and flu, house dust mites, pet fur, pollen, mould, cold air, smoke, exercise, and strong emotions or laughter.

Cystic fibrosis has a single, clear cause: a child inherits two faulty copies of the CFTR gene, one from each parent. CF is autosomal recessive, which means both parents must be carriers (each carrying one faulty copy) for a child to be affected. Carriers themselves are healthy and usually have no idea they carry the gene. When two carriers have a child, there is a 1 in 4 (25%) chance the child will have CF, a 1 in 2 (50%) chance the child will be a healthy carrier, and a 1 in 4 chance the child will neither have CF nor carry the gene. Nothing a parent did or did not do during pregnancy causes CF, and it cannot be caught from another person.

Common signs of asthma in children include wheezing, a cough that keeps coming back (often worse at night, after exercise, or with a cold), breathlessness, and a tight feeling in the chest. Some children simply seem tired, lack energy, or cough a lot without obvious wheezing.

Common signs of cystic fibrosis often appear early and may include a persistent cough that brings up thick mucus, repeated chest and sinus infections, wheezing or breathlessness, poor weight gain or slow growth despite a good appetite, greasy, bulky or foul-smelling stools, constipation or tummy pain, and skin or sweat that tastes unusually salty.

See a doctor without delay if your child has any ongoing breathing symptoms, a long-lasting cough, repeated chest infections, or is not growing as expected. These do not always mean a serious illness, but they deserve a proper check.

Seek urgent or emergency help if a child is struggling to breathe, breathing very fast, unable to speak in full sentences, has lips or skin turning blue or grey, or a reliever inhaler is not helping during a suspected asthma attack. In these situations call your local emergency number straight away.

Asthma has no routine population screening test. Because symptoms come and go and overlap with ordinary coughs and colds, asthma is usually picked up when a parent or doctor notices a pattern of repeated breathing problems over time. There is no test you can do at home to confirm it, but keeping a simple diary of when symptoms happen, what seemed to set them off, and how often a reliever inhaler is needed can help your doctor reach a diagnosis sooner.

Cystic fibrosis, by contrast, is screened for at birth in many countries. A newborn blood-spot (heel-prick) test taken in the first days of life can flag a baby who may have CF by measuring a substance called immunoreactive trypsinogen (IRT). A raised result does not confirm CF on its own; it simply means further testing is needed. Where newborn screening is offered, most cases are found very early, which allows treatment to start before serious problems develop. Families with a known history of CF may also be offered carrier testing before or during pregnancy to understand the chance of passing it on.

Diagnosing asthma starts with the story: the doctor asks about symptoms, when they happen, family history, and triggers, then listens to the chest. In children old enough to cooperate, usually around school age, a breathing test called spirometry measures how much and how fast air is blown out, sometimes before and after a reliever inhaler to see if the airways open up. Younger children often cannot do these tests reliably, so doctors may diagnose asthma from the pattern of symptoms and how the child responds to a trial of asthma medicine. Allergy testing or simple blood tests are sometimes added.

Diagnosing cystic fibrosis usually combines several steps. After a positive newborn screen or suspicious symptoms, the key test is the sweat test, which measures the amount of salt (chloride) in sweat; people with CF have unusually salty sweat. A high result is the most reliable sign of CF. Genetic testing looks for the specific faulty CFTR genes and helps confirm the diagnosis and guide treatment choices. Doctors may add chest imaging, lung function tests, sputum (phlegm) cultures to check for infection, and stool tests to see how well the pancreas is working. CF is not described by cancer-style staging; instead, care is guided by how the lungs, digestion, and other organs are doing over time.

Asthma treatment centres on inhalers, which deliver medicine straight to the airways. There are two main types. A reliever (rescue) inhaler, often blue, opens tight airways quickly during symptoms. A preventer (controller) inhaler, usually containing a low dose of steroid, is taken regularly to calm the underlying inflammation so symptoms happen less often. Younger children often use a spacer, a plastic chamber that makes inhalers easier and more effective to use, and sometimes a face mask. Some children also benefit from tablets such as montelukast, and a small number with severe asthma may be considered for newer injected treatments called biologics. A written asthma action plan from your doctor explains the daily routine and exactly what to do if symptoms worsen.

Cystic fibrosis treatment is broader because CF affects several organs, and it is given by a team. Day-to-day care usually includes:

• Airway clearance — physiotherapy, breathing techniques, and devices (such as PEP devices or oscillating vests) that help loosen and move thick mucus out of the lungs.
• Inhaled medicines — to thin mucus and keep airways open.
• Antibiotics — to prevent and treat chest infections.
• Pancreatic enzyme supplements and nutrition support — taken with food to help digest it, plus a high-calorie diet and vitamins, because children with CF often need many more calories than usual.
• CFTR modulators — a group of newer medicines that help the faulty CFTR protein work better. Whether a child can take them depends on their age and exact gene mutations. For children who are eligible, these medicines have improved lung function and reduced flare-ups.

In advanced lung disease, a lung transplant may be considered for some patients. CF care is delivered by a multidisciplinary team: paediatric lung specialists, physiotherapists, dietitians, nurses, and others working together. Asthma care, too, involves a team of GP or paediatrician, asthma nurse, and pharmacist.

Asthma. There is no cure for asthma, but with the right inhalers and an action plan most children have few or no symptoms and can play, exercise, and sleep normally. Asthma that begins in early childhood sometimes eases or seems to disappear by the teenage years, although it can return later. The realistic goal is good control: rare symptoms, minimal need for the reliever inhaler, and no limits on normal activity.

Cystic fibrosis. CF is a lifelong condition that currently has no cure, but the outlook has improved dramatically over recent decades thanks to earlier diagnosis, organised specialist care, and modern medicines. The Cystic Fibrosis Foundation's 2024 data report that, for babies born in recent years, around half are now predicted to live to age 65 or beyond. These figures are population-level averages drawn from large registries; they describe a group, not a forecast for any individual child, and outcomes vary with the specific gene mutations, organ involvement, and access to care. Your child's own specialist team is best placed to discuss what the future may hold. What is clear is that the day-to-day reality for many children with CF today is very different from a generation ago.

Asthma follow-up is usually straightforward. Children have regular reviews (often once a year, or sooner if control slips) to check inhaler technique, update the action plan, and adjust medicines as they grow. Good habits make a big difference: taking the preventer inhaler every day even when well, using a spacer correctly, keeping away from tobacco smoke, and managing known triggers. If a child needs their reliever inhaler more than a couple of times a week, that is a signal to see the doctor, as it suggests asthma is not fully controlled.

Cystic fibrosis follow-up is more intensive and lifelong. Children are seen regularly at a specialist CF centre, often every few months, for lung function checks, growth and nutrition reviews, infection monitoring, and medicine adjustments. Daily routines of physiotherapy, enzymes with meals, and other medicines become part of family life. Infection prevention matters: keeping up with recommended vaccinations and good hygiene helps reduce chest infections. Emotional support for the child and family is an important part of care, and many CF centres include psychologists and social workers. Schools can be partners too, with a simple plan so staff understand the child's needs.

Because childhood asthma and cystic fibrosis are managed over time rather than fixed by a single operation, the cost of care abroad depends on what your child actually needs rather than one set price. We do not quote figures here; instead, the factors below shape any personalised estimate, which you can request through a free consultation.

• What is being arranged — a one-off specialist assessment and tests is very different from ongoing treatment, a course of medicines, or inpatient care for a chest infection.
• Diagnostic workup — sweat tests, genetic testing, lung function tests, imaging, and laboratory cultures each add to the picture.
• Medicines — inhalers, antibiotics, enzymes, and especially specialist CFTR modulators differ widely in cost and availability.
• Length and type of stay — outpatient visits versus a hospital admission, and how many follow-up appointments are needed.
• Team involvement — the number of specialists (lung doctor, dietitian, physiotherapist) taking part.
• Travel and accommodation — flights, an interpreter, and a place to stay for the family.

To prepare, gather your child's medical records before you travel: previous diagnoses and test results (including any genetic or sweat-test reports), a current medicine list with doses, immunisation history, growth charts, recent chest imaging, and a short summary letter from your current doctor. Clear records help the new team avoid repeating tests and reach a plan faster. We can help you organise and translate these documents.

Turkiye has a large, internationally connected healthcare sector with paediatric hospitals that treat respiratory conditions and offer the diagnostics needed for both asthma and cystic fibrosis. For international families, the practical draws are the availability of specialist paediatric pulmonology (children's lung medicine) teams, modern hospital facilities, and support services for visitors such as interpreters and travel coordination.

Rather than looking for any single "top" hospital, focus on what you can verify:

• Accreditation — check whether the hospital holds recognised international accreditation, such as Joint Commission International (JCI), and whether it has a dedicated paediatric department.
• The right specialists — confirm there is a paediatric pulmonologist and, for CF, a multidisciplinary CF team including physiotherapy and dietetics.
• Experience with the condition — ask how often the centre manages childhood asthma or cystic fibrosis, and whether it can access the specific medicines your child needs.
• Clear communication — make sure you can speak with the team in a language you understand, receive a written plan, and arrange follow-up.
• Continuity of care — agree how results and plans will be shared with your doctor at home for ongoing management.

A good concierge service should help you compare options, verify these points, and arrange a free consultation so you can ask questions before committing.

Asthma cannot be prevented entirely, but symptoms can be reduced. The most powerful step is keeping the home and car completely smoke-free. Beyond that, identifying and reducing known triggers (dust, pet fur, mould, pollen where possible), taking preventer medicine as prescribed, keeping up with flu and other recommended vaccinations, and staying active all help. Regular reviews and good inhaler technique keep asthma well controlled.

Cystic fibrosis cannot be prevented because it is inherited, but families with a known history may choose genetic counselling and carrier testing before or during pregnancy to understand the chances of passing it on. For a child who has CF, day-to-day self-care, sticking to physiotherapy, enzymes, medicines, good nutrition, and infection prevention, makes a real difference over the years.

For either condition, it is always reasonable to seek a second opinion, particularly before starting an intensive new treatment, considering a specialist medicine such as a CFTR modulator, or if you simply want reassurance about the plan. A qualified paediatric specialist can review your child's records and discuss the options. Families interested in newer treatments may also ask their specialist team whether any suitable clinical trials are open.